glutathione cancer pathophysiology and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression: Cancer Cell Glutathione Synthesis in Cancer Cells

In addition, LKB1 and KEAP1/NRF2 pathways synergistically promote metabolic reprogramming toward enhanced glutamine dependence in lung adenocarcinoma with mutated KRAS, and they also enhance the sensitivity of cancer cells to CB-839 (GLS inhibitor) in vitro and in vivo (165)

Many patients use both together

Numerous studies have provided evidence that LA can reverse the advancement and course of MASLD in individuals with insulin resistance to HFD

The REDEFINE 2 trial examined CagriSema in adults with type 2 diabetes, a population that typically shows less weight loss with GLP-1 therapies

In addition, inhibition of GLS has been reported to increase the immunotherapy efficacy of CD8 + T cells (Johnson et al., 2018

E.WoodruffT